A
new statistical data titled as Global Neuromonitoring Devices Market Research Report
(2021-2030) has
been published by Absolute Markets Insights. Different features of recent
trends have been elaborated to give an in-depth analysis of the progress of the
industries. Effective exploratory techniques such as qualitative and quantitative
analysis have been used to discover the accurate data.
For
the effective business outlook, it studies different global regions, such as
North America, Latin America, Asia-Pacific, Japan, and India by considering
different segments such as type, size, as well as applications. SWOT and
Porter’s Five analysis have been used to analyze the informative data such as
cost, prices, revenue, and end-users. This research report has been aggregated
on the basis of various attributes such as manufacturing base, products or
services and raw material to understand the requirements of the businesses.
Apart
from the regional outlook, it throws light on leading industry key players such
as Cadwell Industries Inc., inomed Medizintechnik
GmbH, Integra LifeSciences, Medtronic, Moberg Research Inc., Natus Medical,
Neurosoft, Neurostyle, Neurovision Medical Products, and Nihon Kohden
Corporation to
understand the successful sales strategies of the businesses. Additionally, it
covers various factors which is responsible for the progress of the market. For
better understanding of ups-down stages of the businesses, analysts also focus
on various attributes are limiting the growth of the industries. This
comprehensive data provides the guidelines to discover the global opportunities
for the Neuromonitoring Devices sector in the near future.
Browse the
full report description, along with the ToCs and List of Facts and Figures @ https://www.industryglobalnews24.com/neuromonitoring-devices-market-was-valued-at-us-702233-mn-in-2020
In terms of revenue,
neuromonitoring devices market was valued at US$ 7022.33 Mn in 2020 growing at
a CAGR of +6.8% over the forecast period (2021 – 2030). The study analyses the
market in terms of revenue across all the major regions, which have been
bifurcated into countries.
The biggest driver for the growth
of global neuromonitoring devices market is the need for better risk management
during complex surgical procedures. Hence, the use of intraoperative
neuromonitoring during a surgical procedure helps surgeons to reduce the risks
of impairment to neurophysiological relevant nerve structures. It also prevents
the possible impairment of nerve function which might happen due to improper
positioning of the patient. High rates of neurological disorders due to various
factors such as changes in the social environment, increased stress levels, and
lifestyle changes is the second major factor creating demand and thus,
advancing the growth of neuromonitoring devices market. Other factors
supporting the market growth include increasing postoperative risks of
cerebrovascular disorders and increased demand for automated neurological
monitoring devices in hospitals. In July 2021, NuVasive received Conformité
Européenne (CE) mark for Pulse platform. Global clinical evaluations started in
many countries after that. The latest design update makes Pulse a platform to
assist surgeons in all spine surgery-related procedures. The shortage of
professionals trained to operate neurological monitoring devices is the biggest
restraint in the global neuromonitoring devices market growth. This problem is
higher in developing countries, where technological knowhow is less. However,
this may change in the future because of various companies spending heavily on
the training of medical professionals and efforts of many governments to
increase the role of technology in the field of medicine can boost the global
neuromonitoring devices market in future.
Technological advancement enabling
the development of non-invasive devices and minimally invasive devices is
anticipated to advance the growth of global neuromonitoring devices market over
the forecast period. According to the U.S. Centers for Disease Control and
Prevention (CDC), in the USA, about 4,600 adult day service centers offered
long-term care services for assisted living and similar residential care
communities in 2016. Same could be said for 4,300 hospice care facilities,
12,200 home health agencies, 15,600 nursing homes, and 28,900. Such facilities
always need to buy neuromonitoring devices. Hence, along with such facilities
the market for neuromonitoring devices useful for home care can also increase
in the near future, creating new opportunities for sales in order to cater new
demands.
Global
Neuromonitoring Devices Market: Report Scope
By
Component
·
Systems
·
Accessories
·
Stimulation
Probe
·
Tubes
·
Electrodes
·
Others
·
Services
By
Application
·
Neurosurgery
·
Spine
Surgery
·
Vascular
Surgery
·
Facial
Nerve Surgery
·
Rectal
Surgery
·
Colorectal
Surgery
·
Brain
Mapping
·
Thyroid
Surgery
·
Ear,
Nose and Throat (ENT) Surgery
·
Others
By
End User
·
Hospitals
·
Ambulatory
Surgical Centres
·
Others
By
Distribution Channel
·
Direct
·
Indirect
By
Region
·
North
America
·
Europe
·
Asia
Pacific
·
Middle
East and Africa
·
Latin
America
Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: https://www.absolutemarketsinsights.com/
No comments:
Post a Comment